KP-23172 |
| Catalog No.GC60219 |
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 331253-86-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
KP-23172 is a PI3-K/Akt pathway inhibitor extracted from patent US7196083[1].
KP-23172 (10 µM; 60 min) significantly augments NRP-induced apoptosis [1].
[1]. Xi RG, et al. Roles of PI3-K/Akt pathways in nanoparticle realgar powders-induced apoptosis in U937 cells. Acta Pharmacol Sin. 2008 Mar;29(3):355-63.
Review for KP-23172
Average Rating: 5 (Based on Reviews and 11 reference(s) in Google Scholar.)
Review for KP-23172
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *